Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This is a pilot study evaluating the feasibility of intravenous calcium and magnesium (Ca/Mg)
infusion for prevention of taxane induced neuropathy in patients with early stage breast
cancer receiving adjuvant or neo-adjuvant paclitaxel, either given every 2 weeks for 4 cycles
or every week for 12 weeks.